SCHEMBL4966724

SCHEMBL4966724

N[C@H]1CCCN(P(N)(=O)Nc2ccc(Cl)cc2)C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.53
HSD11B1 P28845 1/20 0.34
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CCR1 P32246 1/20 0.33
GRM5 P41594 1/20 0.33
GAA P10253 2/20 0.33
POLB P06746 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
LMNA P02545 2/20 0.32
RAB9A P51151 3/20 0.31
NPC1 O15118 2/20 0.31
FPR1 P21462 1/20 0.31
FPR2 P25090 1/20 0.31
CNR1 P21554 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4966944 0.88 DPP4 (0.54) DPP4GAARAB9A
SCHEMBL4963263 0.87 DPP4 (0.53) DPP4GAAHRH3LMNARAB9A
SCHEMBL4964917 0.87 DPP4 (0.56) DPP4GAAPOLBRAB9AMAPT
SCHEMBL4963531 0.86 DPP4 (0.56) DPP4POLBLMNARAB9ANPC1
SCHEMBL4966659 0.84 DPP4 (0.50) DPP4GAALMNAMAPTSMN1; SMN2
SCHEMBL4965133 0.84 DPP4 (0.50) DPP4HDAC1HDAC8HDAC6RAB9A
SCHEMBL4968944 0.84 DPP4 (0.53) DPP4HDAC1HDAC8HDAC6GAA
SCHEMBL4964297 0.83 DPP4 (0.49) DPP4GAAPOLBHRH3LMNA
SCHEMBL4966011 0.81 DPP4 (0.53) DPP4HSD11B1HDAC1HDAC8HDAC6
SCHEMBL4966920 0.81 DPP4 (0.50) DPP4RAB9ANPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1489088-B1 NOVEL ALPHA-AMINO-N-(DIAMINOPHOSPHINYL)LACTAM DERIVATIVE NIPPON KAYAKU KK (JP) 2008-08-13 EP disclosed
US-7348318-B2 α-Amino-N-(diaminophosphinyl)lactam derivatives NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-03-25 US disclosed
US-20050164989-A1 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2005-07-28 US disclosed
EP-1489088-A1 NOVEL ALPHA-AMINO-N-(DIAMINOPHOSPHINYL)LACTAM DERIVATIVE Nippon Kayaku Kabushiki Kaisha (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050164989-A1 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative DNPEP, PEPD, ANPEP DPP4 8/4885HSD11B1 2666/4885HDAC1 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.